SS

Seema Singh

Active Director Director DIN 08578319
DIN 08578319 First appointment Oct 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Seema Singh

Data last updated:

Seema Singh is a Director at Alencik Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Alencik Pharmaceuticals Private Limited reported revenue of ₹13.7 Lakh (FY 2024).

DIN 08578319
Primary Designation Director
Industry Chemicals
First Appointment 03 Oct 2019
Oldest Company Age 7 yrs
Largest company Alencik Pharmaceuticals Private Limited · ₹13.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Oct 20192019₹13.7 Lakh (FY 2024)Active

Board colleagues of Seema Singh

NameDINCompanyDesignation
Atul Kumar Singh08578318Alencik Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alencik Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Seema Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Singh

Seema Singh currently holds 1 directorship: Alencik Pharmaceuticals Private Limited (Director, since 03 Oct 2019, revenue ₹13.7 Lakh (FY 2024)).

Seema Singh was first appointed on 03 Oct 2019 as Director at Alencik Pharmaceuticals Private Limited.

The current boards of Seema Singh's companies include Atul Kumar Singh (Alencik Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available